Halozyme Reports First Quarter 2016 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. REGN
2. LITE
3. CRWD
4. AAPL
5. MRVL
6. ABBV
7. CL
8. TFII
9. ORCL
10. PLTR

Go back to Halozyme Reports First Quarter 2016 Financial Results

Halozyme Therapeutics (HALO) Tops Q1 EPS by 4c; FY Revenue Guidance Tops Views

May 9, 2016 4:32 PM EDT

Halozyme Therapeutics (NASDAQ: HALO) reported Q1 EPS of ($0.16), $0.04 better than the analyst estimate of ($0.20). Revenue for the quarter came in at $42.5 million versus the consensus estimate of $29.65 million.

GUIDANCE:

Halozyme Therapeutics sees FY2016 revenue of $130-145 million, versus the consensus of... More